Selegiline Hydrochloride Capsule
Product Images NDC 71205-888

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Selegiline Hydrochloride (NDC 71205-888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-888-30 (500ct)

Label for Selegiline HCl 5mg capsules by Proficient Rx LP. Contains 30 hard gelatin capsules with a white opaque body and blue opaque cap imprinted with "P 659" in black. Distributed by Rising Pharma Holdings, made in the USA. Includes NDC 71205-888-30 and storage instructions at 20°-25°C.*

FDA Label Image

Chemical Structure (Chemstructure)

Chemical structure of Selegiline Hydrochloride showing its molecular framework including a phenyl group and other characteristic features consistent with the compound.*

FDA Label Image

Adverse Reactions Table (Table Adverse Events V2)

A data table listing the incidence of treatment-emergent adverse experiences in a placebo-controlled clinical trial for selegiline hydrochloride. It compares the number of patients reporting various adverse events between selegiline hydrochloride (N=49) and placebo (N=50) groups, including events like nausea, dizziness, abdominal pain, hallucinations, dyskinesias, and others.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.